GlassScriptPhysician profile
James Butler
NPI 1417914748
$524.65
in general payments reported to CMS, 2019-2025
13 companies · $76.78 in 2025
The $76.78 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.94 · 2020: $47.22 · 2021: $110 · 2022: $158 · 2023: $13.41 · 2024: $33.77 · 2025: $76.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $123.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $131.74 | 2019-2025 | Veozah |
| Abbvie INC. | $107.12 | 2021-2024 | |
| Hologic Sales and Service, LLC | $104.87 | 2019-2022 | |
| Duchesnay USA Incorporated | $30.83 | 2019 | |
| Amgen INC. | $25.05 | 2019-2021 | |
| Baxter Healthcare | $24.81 | 2022 | |
| Coopersurgical, INC. | $19.41 | 2020 | |
| Novo Nordisk INC | $16.07 | 2021 | |
| Mayne Pharma Commercial LLC | $14.10 | 2022 | |
| Organon LLC | $13.61 | 2022 | |
| Sumitomo Pharma America, INC. | $13.41 | 2023 | Myfembree |
| Pfizer INC. | $12.13 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.